Sort
10,766 grants matching “checkpoint inhibitor”
Molecular Imaging and Theranostics of Cancer
$982,256Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2021 · CA
Molecular Imaging and Theranostics of Cancer
$981,694Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2020 · CA
Molecular Imaging and Theranostics of Cancer
$981,390Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2018 · CA
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$980,283Pablo Tamayo · University Of California, San Diego · U01 · FY2019 · CA
Comprehensive Assessment of Cancer Immunotherapy Response
$979,163Timothy Perk · Aiq Solutions, Inc. · R44 · FY2023 · CA
Immunological Analysis of Brain Cancer
$979,154Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Regulation of innate lymphocyte function
$978,700Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$977,964Tomas G Neilan · Massachusetts General Hospital · R01 · FY2023 · HL
Combining receptor-targeted alpha particle therapy and immunotherapy to achieve complete responses in metastatic melanoma
$976,668Michael King Schultz · Viewpoint Molecular Targeting, Inc. · R44 · FY2022 · CA
Human Translational Studies of Vascular Thrombosis and Inflammation
$975,922Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Metabolic Influences on Complex Tumor Neighborhoods
$975,000M. Celeste Simon · University Of Pennsylvania · R35 · FY2025 · CA
Reducing Cancer Health Disparities in Detroit
$973,764Ann G Schwartz · Wayne State University · P20 · FY2023 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$972,261Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$972,086Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Exploring DNA damage response pathways as targets for cancer therapy
$972,000Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2025 · CA
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$971,495Tomas G Neilan · Massachusetts General Hospital · R01 · FY2024 · HL
Regulation of PDAC metabolism and immunity by collagen and its cleavage products
$971,140Michael Karin · University Of California, San Diego · U01 · FY2022 · CA
Studies of Human T Regulatory Cells
$970,827Ethan Shevach · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Thoracic and Gastrointestinal Malignancies Branch Clinical Core
$968,567Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
Initiation of DNA Replication in Mammalian Cells
$966,780Mirit Aladjem · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cellular Interactions with Thrombospondin
$965,406David D Roberts · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Metabolic reprogramming of the tumor microenvironment and therapy resistance
$964,319Ernst Lengyel · University Of Chicago · R35 · FY2022 · CA
Metabolic reprogramming of the tumor microenvironment and therapy resistance
$964,319Ernst Lengyel · University Of Chicago · R35 · FY2023 · CA
Human Translational Studies of Vascular Thrombosis and Inflammation
$963,672Yogen Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Molecular Imaging and Theranostics of Cancer
$962,425Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2022 · CA